2. Academic Validation
  3. m6A reader IGF2BP1 facilitates macrophage glycolytic metabolism and fibrotic phenotype by stabilizing THBS1 mRNA to promote pulmonary fibrosis

m6A reader IGF2BP1 facilitates macrophage glycolytic metabolism and fibrotic phenotype by stabilizing THBS1 mRNA to promote pulmonary fibrosis

  • Cell Mol Life Sci. 2025 Apr 12;82(1):157. doi: 10.1007/s00018-025-05673-1.
Yan Hu 1,  Lulu Yang 2,  Liting Huang 2,  Chao Zeng 1,  Siying Ren 3 4 5
Affiliations

Affiliations

  • 1 Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • 2 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital of Central South University, No. 139 Middle Renmin Road, Changsha, 410011, China.
  • 3 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital of Central South University, No. 139 Middle Renmin Road, Changsha, 410011, China. syren@csu.edu.cn.
  • 4 Research Unit of Respiratory Disease, Central South University, Changsha, China. syren@csu.edu.cn.
  • 5 Hunan Diagnosis and Treatment Center of Respiratory Disease, Changsha, China. syren@csu.edu.cn.
PMID: 40220148 DOI: 10.1007/s00018-025-05673-1
Abstract

N6-methyladenosine (m6A) modification, a dynamically reversible epigenetic mechanism, is implicated in pulmonary fibrosis (PF) progression. The function and molecular mechanisms of m6A reader, insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) in PF remain elusive. This study investigates the mechanistic contributions of IGF2BP1 to PF development. We found IGF2BP1 was overexpressed in macrophages of PF mice. IGF2BP1 knockdown markedly attenuated bleomycin (BLM)-induced lung pathology, as evidenced by reduced inflammatory cell infiltration, fibroblast accumulation, Ashcroft fibrosis scores, and hydroxyproline deposition. Furthermore, IGF2BP1 knockdown downregulated PF-associated markers in lung tissues and embryonic lung fibroblasts (ELFs), including TGF-β1, α-SMA, Collagen-I/III, Arg1, CCL18, Ym1, CD163, IL-6, IL-1β, and TIMP1, while decreasing the CD68+/CD163+ macrophage proportion. Mechanistic studies revealed that IGF2BP1 bound to and stabilized thrombospondin-1 (THBS1) in an m6A-dependent manner. THBS1 overexpression rescued the suppression of macrophage M2 polarization caused by IGF2BP1 knockdown. Additionally, THBS1 overexpression counteracted IGF2BP1 knockdown-mediated inhibition of glycolysis, restoring HK2, LDHA, and PKM2 expression, lactate/glucose metabolism, and ATP production. Intriguingly, THBS1 physically interacted with Toll-like Receptor 4 (TLR4), and TLR4 overexpression reversed the inhibitory effect of THBS1 knockdown on macrophage M2 polarization and glycolytic reprogramming. Collectively, our findings demonstrate that IGF2BP1 drives PF progression by stabilizing THBS1 mRNA via m6A modification, thereby promoting TLR4-mediated macrophage M2 polarization and glycolytic activation. This study unveils a novel IGF2BP1/THBS1/TLR4 regulatory axis in PF pathogenesis, offering potential therapeutic targets.

Keywords

Glycolytic metabolism; Insulin-like growth factor 2 mRNA binding protein 1; Macrophage polarization; Pulmonary fibrosis; Thrombospondin-1; n6-methyladenosine.

Figures
Products